Skip to main content
IMRICOR MEDICAL SYSTEMS INC. logo

IMRICOR MEDICAL SYSTEMS INC. — Investor Relations & Filings

Ticker · IMR ISIN · AU0000054942 ASX Manufacturing
Filings indexed 572 across all filing types
Latest filing 2026-05-20 Share Issue/Capital Cha…
Country AU Australia
Listing ASX IMR

About IMRICOR MEDICAL SYSTEMS INC.

https://imricor.com

Imricor Medical Systems Inc. specializes in the development and commercialization of MRI-compatible medical devices designed for cardiac electrophysiology (EP) procedures. The company’s primary focus is enabling interventional cardiac ablation procedures to be performed under real-time MRI guidance, offering an alternative to traditional X-ray fluoroscopy. Key products include the Vision-MR Ablation Catheter and the Advantage-MR EP Recorder/Stimulator System, which are engineered to operate safely and effectively within the high-magnetic-field environment of an MRI scanner. By utilizing real-time MRI, the company aims to provide clinicians with superior soft-tissue visualization and eliminate the ionizing radiation exposure associated with conventional fluoroscopic methods. These technologies are intended to improve the precision and efficacy of treatments for cardiac arrhythmias, such as atrial fibrillation and flutter.

Recent filings

Filing Released Lang Actions
Update - Notification regarding unquoted securities - IMR 6 pages 18.7KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX Appendix 3G notice detailing the issue of unquoted equity securities (options under an employee incentive scheme) to key management personnel and updates to previously announced issuance figures. It relates to a new share issue/capital change rather than financial results, governance materials, or a report publication. This matches the Share Issue/Capital Change category.
2026-05-20 English
Notification of cessation of securities - IMR 4 pages 14.8KB
Share Issue/Capital Change Classification · 78% confidence The document is an ASX Appendix 3H “Notification of cessation of securities,” detailing the expiry and cessation of unquoted equity options and the resulting changes in issued capital. This is a corporate announcement of a change in share capital structure, matching the “Share Issue/Capital Change (SHA)” category rather than a buyback or regulatory notice. There is substantive detail on the capital adjustment itself, not merely a report publication or insider dealing. Hence, SHA is the appropriate classification.
2026-05-20 English
Notification regarding unquoted securities - IMR 6 pages 19.0KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX Appendix 3G notice detailing the issuance of unquoted equity securities under an employee incentive scheme, including number of shares/options issued, recipient details, and compliance with Listing Rules. This is a share issue/capital change announcement, matching the Share Issue/Capital Change category.
2026-05-19 English
Appendix 3Y - SW 2 pages 401.6KB
Director's Dealing Classification · 92% confidence The document is an ASX Appendix 3Y “Change of Director’s Interest Notice” detailing a director’s personal securities transactions, including share and option holdings before and after the change. This is a classic insider dealing/director share transaction report under listing rule 3.19A.2. It does not present financial statements, earnings, or request voting. It clearly falls under the category for Director’s Dealing (insider transactions).
2026-05-19 English
Appendix 3Y - MT 2 pages 403.5KB
Director's Dealing Classification · 89% confidence The document is an ASX Appendix 3Y Change of Director’s Interest Notice – it details the personal acquisition of securities by a company director under the Equity Incentive Plan. This is a report of an insider transaction by a director, matching the definition of Director’s Dealing.
2026-05-19 English
Appendix 3Y - AM 3 pages 406.4KB
Director's Dealing Classification · 99% confidence The document is ASX Appendix 3Y “Change of Director’s Interest Notice” which reports a director’s personal share transactions and changes in relevant interests under ASX Listing Rule 3.19A.2. This is a classic insider trading disclosure by a director, matching the Director’s Dealing category.
2026-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.